Medicis Mulls New Solodyn IP Suit Against Mylan
Medicis Pharmaceutical Corp. is considering another lawsuit over its patent for Solodyn in the wake of Mylan Inc.'s admission that one of its subsidiaries has filed another abbreviated new drug application...To view the full article, register now.
Already a subscriber? Click here to view full article